Delaware’s cannabis industry: A secret shopper investigation finds mislabeling, contamination, and public health risks among gaps in compliance

A “Secret Shopper” investigation conducted by Our Delaware and the National Clinical Directors Consortium revealed alarming compliance issues in Delaware’s cannabis industry. The study discovered instances of mislabeling, product contamination, and the presence of synthetic cannabinoids in cannabis products. The findings highlighted the necessity for better regulation, accurate labeling, and public health protection. A “Secret Shopper” investigation conducted by Our Delaware and the National Clinical Directors Consortium revealed alarming compliance issues in Delaware’s cannabis industry. The study discovered instances of mislabeling, product contamination, and the presence of synthetic cannabinoids in cannabis products. The findings highlighted the necessity for better regulation, accurate labeling, and public health protection.  Read More